U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07082829) titled 'A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age' on June 25.

Brief Summary: Characterize the safety, tolerability and pharmacokinetics of ORX142 following single and multiple doses.

Study Start Date: June 30

Study Type: INTERVENTIONAL

Condition: Excessive Daytime Sleepiness

Intervention: DRUG: ORX142 Tablets

ORX142 Tablets

OTHER: Placebo Tablets

Placebo Tablets

Recruitment Status: RECRUITING

Sponsor: Centessa Pharmaceuticals (UK) Limited

Disclaimer: Curated by HT Syndication....